Skip to main content
. 2013 Aug 30;2013(8):CD001245. doi: 10.1002/14651858.CD001245.pub2
Date Event Description
4 February 2013 New citation required and conclusions have changed A new subgroup analysis was added and the conclusions changed.
4 February 2013 New search has been performed Updated searches completed and a new study added. We included one new study (Hillman 2002) with 505 participants. This study is different in treatment timing and duration of therapy and contributes 26.5% of all participants. The review now includes 10 trials and 1904 participants in total.
21 July 2008 Amended Converted to new review format.
7 February 2003 New search has been performed The results of the recently published STAR‐study, the second largest placebo‐controlled randomised trial of antifibrinolytic treatment in subarachnoid haemorrhage, has been added to the review. This study contributes 33% of all included patients in this review and 39% of the patients included in the comparison of antifibrinolytic treatment versus placebo. Furthermore, a Plain language summary of the review has been added.